Mark Prausnitz

Mark Prausnitz
Alma materStanford University B.S., 1988 Massachusetts Institute of Technology Ph.D., 1994
Known forDrug Delivery
SpouseCindy Weinbaum
ChildrenHannah Prausnitz-Weinbaum, Mia Prausnitz-Weinbaum, Samuel Prausnitz-Weinbaum
AwardsFellow, American Institute for Medical and Biological Engineering (2009)

Fellow, National Academy of Inventors (2014)
Fellow, American Association of Pharmaceutical Scientists (2017)

Fellow, Controlled Release Society (2018)
Scientific career
FieldsBiomedical Engineering
InstitutionsGeorgia Institute of Technology
Doctoral advisorRobert S. Langer, James C. Weaver
Websitehttps://drugdelivery.chbe.gatech.edu/

Mark Robert Prausnitz is an American chemical engineer, currently Regents’ Professor and J. Erskine Love, Jr. Chair in Chemical & Biomolecular Engineering at the Georgia Institute of Technology.[1][2] He also serves as adjunct professor of biomedical engineering at Emory University[3] and Adjunct Professor of Chemical & Biomolecular Engineering at the Korea Advanced Institute of Science and Technology.[4] He is known for pioneering microneedle technology for minimally invasive drug and vaccine administration, which has found applications in transdermal, ocular, oral, and sustained release delivery systems.

He has published over 300 research papers in collaboration with over 100 different senior collaborations in universities, industry partners, and government. His publications have been cited more than 47,000 times with an h-index of 109 as of February 2022.[5] He is also inventor on 70 US patents (issued or pending).[6]

  1. ^ "Laboratory for Drug Delivery". www.chbe.gatech.edu.
  2. ^ "Home | Georgia Tech School of Chemical & Biomolecular Engineering". chbe.gatech.edu.
  3. ^ "Mark R. Prausnitz, PhD". med.emory.edu.
  4. ^ "KAIST".
  5. ^ "Mark Prausnitz". scholar.google.com.
  6. ^ "Mark R. Prausnitz Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com.